Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China

ConclusionWarfarin is the most effective intervention for preventing thromboembolism within 6  months post-bioprosthetic MVR surgery in Chinese patients in sinus rhythm. After 6 months, further warfarin therapy was unnecessary, and aspirin should not be routinely administered.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research